These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets. Chan SL; Morgan NG Eur J Pharmacol; 1998 Jun; 350(2-3):267-72. PubMed ID: 9696417 [TBL] [Abstract][Full Text] [Related]
3. Sigma receptors and sigma ligands: background to a pharmacological enigma. Leonard BE Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S166-70. PubMed ID: 15547782 [TBL] [Abstract][Full Text] [Related]
4. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors. Hieble JP; Ruffolo RR Ann N Y Acad Sci; 1995 Jul; 763():8-21. PubMed ID: 7677390 [TBL] [Abstract][Full Text] [Related]
5. Why imidazoline receptor modulator in the treatment of hypertension? Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385 [TBL] [Abstract][Full Text] [Related]
6. [Sigma-ligands for new therapeutic drugs]. Muramatsu M; Okuyama S; Tanaka M Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):189-98. PubMed ID: 7959411 [TBL] [Abstract][Full Text] [Related]
7. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling. Musgrave IF; Hughes RA J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562 [TBL] [Abstract][Full Text] [Related]
8. Imidazoline receptors: from basic concepts to recent developments. Bousquet P J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-6. PubMed ID: 8642798 [TBL] [Abstract][Full Text] [Related]
9. Novel targets and techniques in imidazoline receptor research. Musgrave IF; Hughes RA Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931 [TBL] [Abstract][Full Text] [Related]
10. Evidence that the ability of imidazoline compounds to stimulate insulin secretion is not due to interaction with sigma receptors. Chan SL; Pallett AL; Clews J; Ramsden CA; Morgan NG Eur J Pharmacol; 1997 Apr; 323(2-3):241-4. PubMed ID: 9128845 [TBL] [Abstract][Full Text] [Related]
11. Imidazoline binding sites and their ligands: an overview of the different chemical structures. Dardonville C; Rozas I Med Res Rev; 2004 Sep; 24(5):639-61. PubMed ID: 15224384 [TBL] [Abstract][Full Text] [Related]
12. Imidazoline receptors and their endogenous ligands. Regunathan S; Reis DJ Annu Rev Pharmacol Toxicol; 1996; 36():511-44. PubMed ID: 8725400 [TBL] [Abstract][Full Text] [Related]
13. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors? Zonnenchein R; Diamant S; Atlas D Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Boronat MA; Olmos G; García-Sevilla JA Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358 [TBL] [Abstract][Full Text] [Related]
15. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Alemany R; Olmos G; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in imidazoline receptor research: ligands--localization and isolation--signaling--functional and clinical studies. Head GA; Gundlach AL; Musgrave IF J Auton Nerv Syst; 1998 Oct; 72(2-3):74-9. PubMed ID: 9851554 [TBL] [Abstract][Full Text] [Related]
18. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors. Culver KE; Szechtman H Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347 [TBL] [Abstract][Full Text] [Related]